WHWK
NASDAQ · Biotechnology
Whitehawk Therapeutics Inc
$3.21
-0.03 (-0.93%)
Open$3.22
Previous Close$3.24
Day High$3.23
Day Low$3.21
52W High$5.50
52W Low$1.97
Volume—
Avg Volume359.8K
Market Cap172.08M
P/E Ratio—
EPS$-3.03
SectorBiotechnology
Analyst Ratings
Buy
14 analysts
Price Target
+439.3% upside
Current
$3.21
$3.21
Target
$17.31
$17.31
$14.24
$17.31 avg
$28.90
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 8.05M | 10.36M | 8.91M |
| Net Income | -23,204,136 | -26,870,461 | 2.41M |
| Profit Margin | -288.3% | -273.9% | 27.1% |
| EBITDA | -30,480,324 | -37,257,215 | 4.31M |
| Free Cash Flow | — | — | 1.46M |
| Rev Growth | -22.3% | -22.3% | +22.0% |
| Debt/Equity | — | — | 0.54 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |